These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33382995)

  • 1. Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood.
    Bhattoa HP; Cavalier E; Eastell R; Heijboer AC; Jørgensen NR; Makris K; Ulmer CZ; Kanis JA; Cooper C; Silverman SL; Vasikaran SD;
    Clin Chim Acta; 2021 Apr; 515():16-20. PubMed ID: 33382995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.
    Szulc P; Naylor K; Hoyle NR; Eastell R; Leary ET;
    Osteoporos Int; 2017 Sep; 28(9):2541-2556. PubMed ID: 28631236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability].
    Szulc P; Naylor K; Pickering ME; Hoyle N; Eastell R; Leary E
    Ann Biol Clin (Paris); 2018 Aug; 76(4):373-391. PubMed ID: 30078776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges.
    Bauer D; Krege J; Lane N; Leary E; Libanati C; Miller P; Myers G; Silverman S; Vesper HW; Lee D; Payette M; Randall S
    Osteoporos Int; 2012 Oct; 23(10):2425-33. PubMed ID: 22797491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism.
    Cavalier E; Eastell R; Rye Jørgensen N; Makris K; Tournis S; Vasikaran S; Kanis JA; Cooper C; Pottel H; Morris HA;
    Clin Chem Lab Med; 2019 Sep; 57(10):1546-1555. PubMed ID: 31085740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmonization of commercial assays for PINP; the way forward.
    Vasikaran SD; Bhattoa HP; Eastell R; Heijboer AC; Jørgensen NR; Makris K; Ulmer C; Kanis JA; Cooper C; Silverman S; Cavalier E
    Osteoporos Int; 2020 Mar; 31(3):409-412. PubMed ID: 31975180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related trends and reference intervals of cross-linked C-telopeptide of type I collagen and procollagen type I N-propeptide from a reference population of Sri Lankan adult women.
    Rathnayake H; Lekamwasam S; Wickramatilake C; De Zoysa E; Lenora J
    Arch Osteoporos; 2021 Nov; 16(1):164. PubMed ID: 34727246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
    Diemar SS; Lylloff L; Rønne MS; Møllehave LT; Heidemann M; Thuesen BH; Johannesen J; Schou AJ; Husby S; Wedderkopp N; Mølgaard C; Jørgensen NR
    Bone; 2021 May; 146():115879. PubMed ID: 33561588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M; Li Y; Deng W; Zhang Z; Deng Z; Hu Y; Xia W; Xu L
    PLoS One; 2014; 9(8):e103841. PubMed ID: 25117452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
    Crandall CJ; Vasan S; LaCroix A; LeBoff MS; Cauley JA; Robbins JA; Jackson RD; Bauer DC
    J Bone Miner Res; 2018 Jul; 33(7):1199-1208. PubMed ID: 29923225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.
    Vasikaran S; Cooper C; Eastell R; Griesmacher A; Morris HA; Trenti T; Kanis JA
    Clin Chem Lab Med; 2011 Aug; 49(8):1271-1274. PubMed ID: 21605012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current use of bone turnover markers in the management of osteoporosis.
    Brown JP; Don-Wauchope A; Douville P; Albert C; Vasikaran SD
    Clin Biochem; 2022; 109-110():1-10. PubMed ID: 36096182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
    Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z; Jin X; Bian P; Li X; Chen J
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition.
    Shieh A; Karlamangla AS; Gossiel F; Eastell R; Greendale GA
    J Clin Endocrinol Metab; 2024 May; 109(6):1580-1589. PubMed ID: 38087944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM).
    Cavalier E; Eastell R; Jørgensen NR; Makris K; Tournis S; Vasikaran S; Kanis JA; Cooper C; Pottel H; Morris HA;
    Calcif Tissue Int; 2021 Jun; 108(6):785-797. PubMed ID: 33661343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trunk and Lower Extremity Movement Patterns, Stress Fracture Risk Factors, and Biomarkers of Bone Turnover in Military Trainees.
    Mauntel TC; Marshall SW; Hackney AC; Pietrosimone BG; Cameron KL; Peck KY; Trump JR; Padua DA
    J Athl Train; 2020 Jul; 55(7):724-732. PubMed ID: 32702112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein-a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism.
    Cavalier E; Lukas P; Bottani M; Aarsand AK; Ceriotti F; Coşkun A; Díaz-Garzón J; Fernàndez-Calle P; Guerra E; Locatelli M; Sandberg S; Carobene A;
    Osteoporos Int; 2020 Aug; 31(8):1461-1470. PubMed ID: 32270253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
    Vasikaran S; Eastell R; Bruyère O; Foldes AJ; Garnero P; Griesmacher A; McClung M; Morris HA; Silverman S; Trenti T; Wahl DA; Cooper C; Kanis JA;
    Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.